Occupe actuellement des postes chez Novocure Ltd, OptiNose Inc and Minerva Neurosciences Inc
Position | Company | Period |
---|---|---|
Executive Chairman of the Board | Novocure Ltd | 11 mai 2016 - |
Independent Director | OptiNose Inc | 1 janvier 2010 - |
Lead Independent Director | Minerva Neurosciences Inc | 5 février 2018 - |
Director | Minerva Neurosciences Inc | 11 décembre 2017 - 5 février 2018 |
Independent Director | Zoetis Inc | 3 février 2015 - 12 mai 2016 |
Chairman of the Board | Novocure Ltd | 1 janvier 2004 - 11 mai 2016 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-12 | 2024-03-08 |
Elanco Animal Health Inc
(ELAN)
|
A Achat |
15 000
+32.4%
16,30244 500 USD |
15 000 +32.4% | 16,30 | 244 500 USD | |
2022-08-03 | 2022-08-02 |
Novocure Ltd
(NVCR)
|
V Vente |
837
-0.2%
69,6658 305 USD |
837 -0.2% | 69,66 | 58 305 USD | |
2022-03-09 | 2022-03-08 |
Novocure Ltd
(NVCR)
|
V Vente |
2 385
-0.4%
70,10167 189 USD |
2 385 -0.4% | 70,10 | 167 189 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
600
-0.1%
216,69130 016 USD |
600 -0.1% | 216,69 | 130 016 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
500
-0.1%
214,67107 333 USD |
500 -0.1% | 214,67 | 107 333 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
1 500
-0.3%
213,35320 021 USD |
1 500 -0.3% | 213,35 | 320 021 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
600
-0.1%
211,28126 766 USD |
600 -0.1% | 211,28 | 126 766 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
521
-0.1%
210,18109 504 USD |
521 -0.1% | 210,18 | 109 504 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
2 200
-0.4%
209,34460 555 USD |
2 200 -0.4% | 209,34 | 460 555 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
4 500
-0.8%
207,80935 118 USD |
4 500 -0.8% | 207,80 | 935 118 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
1 284
-0.2%
206,35264 956 USD |
1 284 -0.2% | 206,35 | 264 956 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
1 600
-0.3%
205,43328 690 USD |
1 600 -0.3% | 205,43 | 328 690 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
1 972
-0.3%
204,28402 834 USD |
1 972 -0.3% | 204,28 | 402 834 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
2 555
-0.4%
203,25519 311 USD |
2 555 -0.4% | 203,25 | 519 311 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
4 388
-0.8%
202,16887 069 USD |
4 388 -0.8% | 202,16 | 887 069 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
4 125
-0.7%
201,55831 377 USD |
4 125 -0.7% | 201,55 | 831 377 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
4 338
-0.7%
199,71866 355 USD |
4 338 -0.7% | 199,71 | 866 355 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
10 563
-1.8%
198,982 101 794 USD |
10 563 -1.8% | 198,98 | 2 101 794 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
13 612
-2.2%
197,832 692 876 USD |
13 612 -2.2% | 197,83 | 2 692 876 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
24 338
-3.8%
197,004 794 659 USD |
24 338 -3.8% | 197,00 | 4 794 659 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
8 814
-1.4%
196,071 728 187 USD |
8 814 -1.4% | 196,07 | 1 728 187 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
1 600
-0.2%
194,94311 904 USD |
1 600 -0.2% | 194,94 | 311 904 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
2 090
-0.3%
193,57404 563 USD |
2 090 -0.3% | 193,57 | 404 563 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
1 900
-0.3%
192,52365 796 USD |
1 900 -0.3% | 192,52 | 365 796 USD | |
2021-04-15 | 2021-04-13 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
1 400
-0.2%
191,26267 768 USD |
1 400 -0.2% | 191,26 | 267 768 USD | |
2021-04-02 | 2021-04-01 |
Novocure Ltd
(NVCR)
|
V Vente |
7 928
-1.2%
134,121 063 303 USD |
7 928 -1.2% | 134,12 | 1 063 303 USD | |
2020-08-03 | 2020-07-31 |
Novocure Ltd
(NVCR)
|
V Vente |
896
-0.1%
76,3968 444 USD |
896 -0.1% | 76,39 | 68 444 USD | |
2020-05-12 | 2020-05-11 |
Novocure Ltd
(NVCR)
|
V Vente |
31 332
-4.6%
63,731 996 726 USD |
31 332 -4.6% | 63,73 | 1 996 726 USD | |
2020-05-11 | 2020-05-08 |
Novocure Ltd
(NVCR)
|
V Vente |
31 903
-4.5%
63,502 025 872 USD |
31 903 -4.5% | 63,50 | 2 025 872 USD | |
2020-05-11 | 2020-05-07 |
Novocure Ltd
(NVCR)
|
V Vente |
30 993
-4.5%
64,742 006 518 USD |
30 993 -4.5% | 64,74 | 2 006 518 USD | |
2020-05-07 | 2020-05-06 |
Novocure Ltd
(NVCR)
|
V Vente |
29 881
-5.0%
64,271 920 452 USD |
29 881 -5.0% | 64,27 | 1 920 452 USD | |
2020-05-07 | 2020-05-05 |
Novocure Ltd
(NVCR)
|
V Vente |
30 283
-4.8%
62,471 891 718 USD |
30 283 -4.8% | 62,47 | 1 891 718 USD | |
2020-03-10 | 2020-03-06 |
Novocure Ltd
(NVCR)
|
V Vente |
4 320
-0.8%
69,53300 387 USD |
4 320 -0.8% | 69,53 | 300 387 USD | |
2020-03-02 | 2020-02-28 |
Novocure Ltd
(NVCR)
|
V Vente |
3 893
-0.8%
72,22281 133 USD |
3 893 -0.8% | 72,22 | 281 133 USD | |
2020-01-22 | 2020-01-17 |
Novocure Ltd
(NVCR)
|
VP Vente planifiée |
133 777
-20.8%
95,0012 708 815 USD |
133 777 -20.8% | 95,00 | 12 708 815 USD | |
2019-07-01 | 2019-06-27 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
3 500
+15.5%
5,5019 250 USD |
3 500 +15.5% | 5,50 | 19 250 USD | |
2019-06-03 | 2019-05-30 |
Novocure Ltd
(NVCR)
|
V Vente |
48 100
-5.4%
53,072 552 523 USD |
48 100 -5.4% | 53,07 | 2 552 523 USD | |
2019-05-31 | 2019-05-29 |
Novocure Ltd
(NVCR)
|
V Vente |
1 900
-0.2%
53,10100 881 USD |
1 900 -0.2% | 53,10 | 100 881 USD | |
2019-05-10 | 2019-05-09 |
Novocure Ltd
(NVCR)
|
V Vente |
31 460
-3.4%
47,371 490 386 USD |
31 460 -3.4% | 47,37 | 1 490 386 USD | |
2019-05-09 | 2019-05-08 |
Novocure Ltd
(NVCR)
|
V Vente |
32 218
-3.6%
47,521 531 032 USD |
32 218 -3.6% | 47,52 | 1 531 032 USD | |
2019-05-09 | 2019-05-07 |
Novocure Ltd
(NVCR)
|
V Vente |
32 098
-3.7%
47,671 530 112 USD |
32 098 -3.7% | 47,67 | 1 530 112 USD | |
2019-05-07 | 2019-05-06 |
Novocure Ltd
(NVCR)
|
V Vente |
29 038
-3.4%
48,071 395 915 USD |
29 038 -3.4% | 48,07 | 1 395 915 USD | |
2019-05-06 | 2019-05-03 |
Novocure Ltd
(NVCR)
|
V Vente |
29 966
-3.7%
45,211 354 643 USD |
29 966 -3.7% | 45,21 | 1 354 643 USD | |
2019-03-01 | 2019-02-28 |
Novocure Ltd
(NVCR)
|
V Vente |
3 097
-0.3%
53,68166 247 USD |
3 097 -0.3% | 53,68 | 166 247 USD | |
2018-12-26 | 2018-12-20 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
2 000
+9.7%
6,5013 000 USD |
2 000 +9.7% | 6,50 | 13 000 USD | |
2018-12-12 | 2018-12-11 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
4 000
+24.1%
7,9531 800 USD |
4 000 +24.1% | 7,95 | 31 800 USD | |
2018-12-12 | 2018-12-10 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
2 000
+13.7%
8,0016 000 USD |
2 000 +13.7% | 8,00 | 16 000 USD | |
2018-11-21 | 2018-11-20 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
2 000
+15.9%
8,2016 400 USD |
2 000 +15.9% | 8,20 | 16 400 USD | |
2018-10-15 | 2018-10-11 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
600
+5.0%
10,006 000 USD |
600 +5.0% | 10,00 | 6 000 USD | |
2018-09-19 | 2018-09-17 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
1 800
+17.6%
10,5018 900 USD |
1 800 +17.6% | 10,50 | 18 900 USD | |
2018-09-17 | 2018-09-14 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
200
+2.0%
10,502 100 USD |
200 +2.0% | 10,50 | 2 100 USD | |
2018-09-17 | 2018-09-13 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
2 000
+25.0%
10,5021 000 USD |
2 000 +25.0% | 10,50 | 21 000 USD | |
2018-09-11 | 2018-09-11 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
4 011
+100.3%
9,7238 987 USD |
4 011 +100.3% | 9,72 | 38 987 USD | |
2018-09-11 | 2018-09-10 |
Minerva Neurosciences Inc
(NERV)
|
A Achat |
4 000
+inf%
9,8839 520 USD |
4 000 +inf% | 9,88 | 39 520 USD |